Literature DB >> 6602220

Structure of glycosylated and unglycosylated gag and gag-pol precursor proteins of Moloney murine leukemia virus.

C J Saris, J van Eenbergen, R M Liskamp, H P Bloemers.   

Abstract

Precursor polyproteins containing translational products of the gag gene of Moloney murine leukemia virus were purified by gel electrophoresis and cleaved into large fragments by hydroxylamine, mild acid hydrolysis, or cyanogen bromide. The hydroxylamine cleavage method (specific for asparagine-glycine bonds) was adapted especially for this study. The electrophoretic mobility and antigenicity of the fragments and, in some cases, the presence or absence of [35S]methionine revealed detailed information on the structure of Pr65gag, gPr80gag, and Pr75gag (the unglycosylated variant of gPr80gag formed in vivo in the presence of tunicamycin or in vitro in a reticulocyte cell-free system). When compared with Pr65gag, gPr80gag contains 7,000 daltons of additional amino acids, presumably as, or as part of, a leader sequence at or very close to its N terminus. We present evidence that this leader may have replaced part of the p15 sequence. Furthermore, gPr80gag contains three separate carbohydrate groups. One is attached to the presumed leader sequence or to the p15 domain, and two are attached to the p30 domain. Each of the Moloney murine leukemia virus gag precursor proteins Pr65gag, gPr80gag, and Pr75gag corresponds with a read-through product into the pol gene. We designated these products Pr180gag-pol, gPr200gag-pol, and Pr190gag-pol (the unglycosylated variant of gPr200gag-pol), respectively. gPr200gag-pol contains all of the extra amino acids and carbohydrate groups present in gPr80gag and at least one carbohydrate group in its pol sequences.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602220      PMCID: PMC256560     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus.

Authors:  D Zaanie; A L Gielkens; M J Dekker-michielsen; H P Bloemers
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

2.  Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus: synthesis, identification, and processing.

Authors:  D Van Zaane; J A Dekker-Michielsen; H P Bloemers
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

3.  Intracistronic mapping of the murine type C viral gag gene by use of conditional lethal replication mutants.

Authors:  R K Reynolds; J R Stephenson
Journal:  Virology       Date:  1977-09       Impact factor: 3.616

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

7.  gag Gene of mammalian type-C RNA tumour viruses.

Authors:  M Barbacid; J R Stephenson; S A Aaronson
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

8.  Measurement of the sequence complexity of cloned Moloney murine leukemia virus 60 to 70S RNA: evidence for a haploid genome.

Authors:  H Fan; M Paskind
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

9.  Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells.

Authors:  J Ledbetter; R C Nowinski
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

10.  Characterization of molecular species carrying gross cell surface antigen.

Authors:  H W Snyder; E Stockert; E Fleissner
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

View more
  12 in total

1.  A new retroelement constituted by a natural alternatively spliced RNA of murine replication-competent retroviruses.

Authors:  Laurent Houzet; Jean Luc Battini; Eric Bernard; Valerie Thibert; Marylène Mougel
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

2.  Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA.

Authors:  J Colicelli; S P Goff
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane.

Authors:  E A Pillemer; D A Kooistra; O N Witte; I L Weissman
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

4.  The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.

Authors:  Yoshiko Usami; Sergei Popov; Heinrich G Göttlinger
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli.

Authors:  N Tanese; M J Roth; S P Goff
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.

Authors:  S M Watanabe; N E Rosenberg; O N Witte
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

7.  Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.

Authors:  F Shang; H Huang; K Revesz; H C Chen; R Herz; A Pinter
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses.

Authors:  A Corbin; A C Prats; J L Darlix; M Sitbon
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors.

Authors:  C Berlioz; J L Darlix
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

Review 10.  Characterization of gP85gag as an antigen recognized by Moloney leukemia virus-specific cytolytic T cell clones that function in vivo.

Authors:  F A van der Hoorn; T Lahaye; V Müller; M A Ogle; H D Engers
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.